Newsfeeds Archive - Page 231 of 19074

1 minute read

June 11, 8:04 AM

The Learning Series will introduce quantum technologies, applications, and resources that can be incorporated into research, courses and curriculaClemson University will be the first university to integrate the Faculty

IONQ

2 minute read

Uncategorized

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In Q2

By Avi Kapoor

June 11, 8:04 AM

The most oversold stocks in the real estate sector presents an opportunity to buy into undervalued companies. The…

CSGP

4 minute read

Analyst Ratings

A Glimpse Into The Expert Outlook On Cardlytics Through 7 Analysts

By Benzinga Insights

June 11, 8:01 AM

Cardlytics (NASDAQ:CDLX) has been analyzed by 7 analysts in the last three months, revealing a diverse range of…

CDLX

3 minute read

Analyst Ratings

Cracking The Code: Understanding Analyst Reviews For Bitdeer Technologies

By Benzinga Insights

June 11, 8:01 AM

Bitdeer Technologies (NASDAQ:BTDR) has been analyzed by 10 analysts in the last three months, revealing a diverse range…

BTDR

3 minute read

Analyst Ratings

Evaluating Ambarella: Insights From 7 Financial Analysts

By Benzinga Insights

June 11, 8:01 AM

7 analysts have expressed a variety of opinions on Ambarella (NASDAQ:AMBA) over the past quarter, offering a diverse…

AMBA

3 minute read

Analyst Ratings

Critical Insights From R1 RCM Analyst Ratings: What You Need To Know

By Benzinga Insights

June 11, 8:00 AM

8 analysts have shared their evaluations of R1 RCM (NASDAQ:RCM) during the recent three months, expressing a mix…

RCM

1 minute read

FDA
News

60 Degrees Pharmaceuticals Announces FDA Orphan Drug Designation For Tafenoquine To Treat Acute Babesiosis

By Benzinga Newsdesk

June 11, 8:00 AM

With the tafenoquine for acute babesiosis orphan drug designation, 60 Degrees Pharmaceuticals now qualifies for certain incentives, including market exclusivity, tax credits, and exemption from certain FDA filing fees.60

SXTP

3 minute read

Analyst Ratings

Key Takeaways From Pegasystems Analyst Ratings

By Benzinga Insights

June 11, 8:00 AM

In the preceding three months, 8 analysts have released ratings for Pegasystems (NASDAQ:PEGA), presenting a wide array of…

PEGA

3 minute read

Analyst Ratings

7 Analysts Have This To Say About Dayforce

By Benzinga Insights

June 11, 8:00 AM

In the preceding three months, 7 analysts have released ratings for Dayforce (NYSE:DAY), presenting a wide array of…

DAY

2 minute read

Toyota’s Certification Crisis Extends Beyond Japan, Could Impact EU Operations

By Shivani Kumaresan

June 11, 7:59 AM

Toyota Motor Corp. faces severe implications worldwide after discrepancies in vehicle certifications breach United Nations standards, impacting operations across 62 countries including the EU.

DIVD

Latest news

IonQ And South Carolina Quantum Partner To Launch Faculty & Researcher Quantum Learning Series

Top 3 Real Estate Stocks Which Could Rescue Your Portfolio In Q2

A Glimpse Into The Expert Outlook On Cardlytics Through 7 Analysts

Cracking The Code: Understanding Analyst Reviews For Bitdeer Technologies

Evaluating Ambarella: Insights From 7 Financial Analysts

Critical Insights From R1 RCM Analyst Ratings: What You Need To Know

60 Degrees Pharmaceuticals Announces FDA Orphan Drug Designation For Tafenoquine To Treat Acute Babesiosis

Key Takeaways From Pegasystems Analyst Ratings

7 Analysts Have This To Say About Dayforce

Toyota’s Certification Crisis Extends Beyond Japan, Could Impact EU Operations